Razoxane

N/A

Report date: 2024/09/05 17:24:04

Base Information

Drug NameRazoxane
Drug Alias NameTRP-1001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase II inhibitors
TargetsTopoisomerase II
Therapy Area/IndicationsSarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTRYP Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTRYP Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsSarcoma

Other Information

ATC CodeN/A
Related LinksN/A